Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development - PubMed (original) (raw)
. 1987 Nov;70(5):1316-24.
Affiliations
- PMID: 3117132
Free article
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
M R Loken et al. Blood. 1987 Nov.
Free article
Abstract
A panel of B lymphoid-reactive monoclonal antibodies was used to analyze the phenotypic changes that accompany B lymphocyte development in normal human bone marrow. The B lymphoid cells were identified using light scattering and the expression of CD19 on a flow cytometer. Quantitative three-color immunofluorescence was then used to correlate other cell surface antigens on these cells identified as B lymphoid in normal marrow. CD10 and CD20 identified almost exclusive populations and provided a convenient means of discriminating between the less and more mature B lineage cells. The CD10+ cells could be further subdivided using CD34. The population of CD19+, CD10+, CD34+ cells comprised only 0.6% of marrow cells, but these contained the majority of terminal deoxynucleotidyl transferase (TdT+) cells. In the assessment of class II antigens, HLA-DR was expressed on all B lineage cells whereas HLA-DP preceded HLA-DQ in appearance during the developmental process. Among the later antigens expressed on B lineage cells, cell surface IgM, CD20, and HLA-DQ were expressed at essentially the same time. Cell surface CD10 was lost at the time when CD21 and CD22 were acquired on the cell surface. These data illustrate that multiparameter flow cytometry can be used to define a continuous progression of stages of B lymphocyte development based on cell surface antigen expression even though these cells represent a minor fraction of normal marrow cells.
Similar articles
- Multiparameter flow cytometric analysis of human fetal bone marrow B cells.
LeBien TW, Wörmann B, Villablanca JG, Law CL, Steinberg LM, Shah VO, Loken MR. LeBien TW, et al. Leukemia. 1990 May;4(5):354-8. Leukemia. 1990. PMID: 1697009 - Flow cytometric analysis of normal B lymphoid development.
Loken MR, Shah VO, Hollander Z, Civin CI. Loken MR, et al. Pathol Immunopathol Res. 1988;7(5):357-70. doi: 10.1159/000157129. Pathol Immunopathol Res. 1988. PMID: 3266012 - The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C, Boiron JM, Boucheix C, Cantaloube JF, Lavabre-Bertrand T, Attal M, Brochier J, Maraninchi D, Bataille R, Klein B. Duperray C, et al. J Immunol. 1990 Dec 1;145(11):3678-83. J Immunol. 1990. PMID: 1700990 - Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM, Haissig S, Ledbetter JA, Fidler P, Myers DE, Kuebelbeck V, Weisdorf D, Gajl-Peczalska K, Kersey JH, Ramsay NK. Uckun FM, et al. Blood. 1992 Jun 15;79(12):3369-79. Blood. 1992. PMID: 1375851
Cited by
- What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
D'Arena G, Vitale C, Pietrantuono G, Villani O, Mansueto G, D'Auria F, Statuto T, D'Agostino S, Sabetta R, Tarasco A, Innocenti I, Autore F, Fresa A, Valvano L, Tomasso A, Cafaro L, Lamorte D, Laurenti L. D'Arena G, et al. Cancers (Basel). 2024 Jan 22;16(2):469. doi: 10.3390/cancers16020469. Cancers (Basel). 2024. PMID: 38275909 Free PMC article. - Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab.
Lopedote P, Shadman M. Lopedote P, et al. Cancer Manag Res. 2023 Mar 14;15:257-264. doi: 10.2147/CMAR.S381493. eCollection 2023. Cancer Manag Res. 2023. PMID: 36941881 Free PMC article. Review. - Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates.
Verstegen NJM, Pollastro S, Unger PA, Marsman C, Elias G, Jorritsma T, Streutker M, Bassler K, Haendler K, Rispens T, Schultze JL, Ten Brinke A, Beyer M, van Ham SM. Verstegen NJM, et al. Elife. 2023 Mar 2;12:e83578. doi: 10.7554/eLife.83578. Elife. 2023. PMID: 36861964 Free PMC article. - Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD.
Shi M, Chu F, Jin T, Zhu J. Shi M, et al. CNS Neurosci Ther. 2022 Jul;28(7):981-991. doi: 10.1111/cns.13836. Epub 2022 Apr 15. CNS Neurosci Ther. 2022. PMID: 35426485 Free PMC article. Review. - The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement.
Wang S, Zhang Y, Meng W, Dong Y, Zhang S, Teng L, Liu Y, Li L, Wang D. Wang S, et al. Cells. 2021 Oct 16;10(10):2776. doi: 10.3390/cells10102776. Cells. 2021. PMID: 34685756 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials